Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade

European Journal of Biochemistry

Volumn 269, Issue 16, 2002, Pages 3945-3957

  Kobayashi, Hiroshi ^a   Suzuki, Mika ^a   Kanayama, Naohiro ^a   Nishida, Takashi ^b   Takigawa, Masaharu ^b   Terao, Toshihiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bikunin; Extracellular signal regulated kinase; Tumor invasion; uPA receptor; Urokinase type plasminogen activator

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEINASE INHIBITOR; ULINASTATIN; UROKINASE; UROKINASE RECEPTOR; VANADATE SODIUM;

ARTICLE; CELL LINE; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BONE NEOPLASMS; BUTADIENES; CARCINOMA; CHONDROSARCOMA; DEPRESSION, CHEMICAL; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NITRILES; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TRYPSIN INHIBITOR, KUNITZ SOYBEAN; TUMOR CELLS, CULTURED;

EID: 0036039046     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.03068.x     Document Type: Article

References (62)

1. Molecular aspects of tumor cell invasion and metastasis
2. Biology and biochemistry of proteinases in tumor invasion
3. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
4. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype
5. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
6. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
7. The role of the plasminogen activation system in angiogenesis and metastasis
8. The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion
9. Urokinase receptor and colorectal cancer survival
10. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion
11. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
12. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells
13. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy
14. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells
15. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549
16. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells
17. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
18. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes
19. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification
20. Transcriptional activation of the urokinase receptor gene in invasive colon cancer
21. Urokinase receptor in human malignant mesothelioma cells: Role in tumor cell mitogenesis and proteolysis
22. The alpha1-microglobulin/bikunin gene: Characterization in mouse and evolution
23. 2+ in human neutrophils and HUVEC cells
24. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells
25. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways
26. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
27. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)
28. Structure and function analysis of urinary trypsin inhibitor (UTI): Identification of binding domains and signaling property of UTI by analysis of truncated proteins
29. A simple and rapid crystal violet uptake sensitivity test for anticancer agents
30. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation
31. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes
32. A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome
33. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor
34. Expression and localization of two low molecular weight GTP-binding proteins, Rab8 and Rab10, by epitope tag
35. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression
36. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis
37. Identity of urinary trypsin inhibitor-binding protein to link protein
38. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate
39. Urokinase receptor. An activation antigen in human T lymphocytes
40. Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells
41. A synthetic inhibitor of the mitogen-activated protein kinase cascade
42. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
43. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases
44. Plasminogen activators, tissue degradation, and cancer
45. Activations of mitogen-activated protein kinases and phospholipase D in A7r5 vascular smooth muscle cells
46. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase
47. Activation of mitogen-activated protein kinase and phosphatidylinositol 3′-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes
48. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
49. Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells
50. Regulation of cell motility by mitogen-activated protein kinase
51. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
52. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1
53. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules
54. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
55. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models
56. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor
57. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis
58. Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor
59. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells
60. Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes
61. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor
62. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells